To evaluate the clinical and immunologic outcomes of DC (dendritic cell) vaccine with interleukin (IL)-2 and IFN-alpha 2a in metastatic renal cell carcinoma patients.
Alessio Mylonas, Yichen Wang, Jiaqi Chen
Jacques Fellay, Christian Axel Wandall Thorball, Nicolas Meyer
Vassily Hatzimanikatis, Maria Masid Barcon, Ming Yang